Technical Analysis for ZGNX - Zogenix, Inc.

Grade Last Price % Change Price Change
D 20.95 -1.23% -0.26
ZGNX closed down 1.23 percent on Monday, March 1, 2021, on 67 percent of normal volume.
Earnings due: Mar 2
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical ZGNX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -1.23%
MACD Bearish Signal Line Cross Bearish -1.23%
New Downtrend Bearish -1.23%
50 DMA Support Bullish -1.23%
Wide Range Bar Range Expansion -1.23%
Bearish Engulfing Bearish -5.46%
Fell Below 200 DMA Bearish -5.46%
Older End-of-Day Signals for ZGNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 5 hours ago
Down 1% about 6 hours ago
60 Minute Opening Range Breakdown about 6 hours ago
Up 2% about 11 hours ago
Up 1% about 11 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Zogenix, Inc. Description

Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache. The company's lead product candidate, Zohydro, a single-entity extended-release hydrocodone, which has completed Phase III clinical trials for the treatment of moderate to severe chronic pain requiring around-the-clock opioid therapy. It is also developing Relday, an injectable formulation of risperidone, which is in a Phase I clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. Zogenix, Inc. markets and sells its Sumavel DosePro to wholesale pharmaceutical distributors and retail pharmacies in the United States. It has a licensing and distribution agreement with Desitin Arzneimittel GmbH to develop and commercialize DosePro in the European Union, Norway, Switzerland, and Turkey. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Pharmaceutical Pain Symptoms Opioid Schizophrenia Chronic Pain Nervous System Disorders Central Nervous System Disorders Morphinans Neurochemistry Ketones Migraine European Union Cell Signaling Headache Retail Pharmacies Bipolar Disorder Hydrocodone Treatment Of Migraine Severe Chronic Pain Treatment Of Central Nervous System Disorders Indoles Moderate To Severe Chronic Pain Pharmaceutical Distributors Relday Triptans

Is ZGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 32.42
52 Week Low 16.65
Average Volume 920,316
200-Day Moving Average 23.22
50-Day Moving Average 20.64
20-Day Moving Average 22.00
10-Day Moving Average 22.47
Average True Range 1.05
ADX 25.69
+DI 23.55
-DI 26.83
Chandelier Exit (Long, 3 ATRs ) 20.53
Chandelier Exit (Short, 3 ATRs ) 21.86
Upper Bollinger Band 24.17
Lower Bollinger Band 19.82
Percent B (%b) 0.26
BandWidth 19.79
MACD Line 0.45
MACD Signal Line 0.64
MACD Histogram -0.1971
Fundamentals Value
Market Cap 1.17 Billion
Num Shares 55.7 Million
EPS -3.32
Price-to-Earnings (P/E) Ratio -6.31
Price-to-Sales 158.59
Price-to-Book 2.91
PEG Ratio -0.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.53
Resistance 3 (R3) 22.61 22.18 22.26
Resistance 2 (R2) 22.18 21.78 22.13 22.17
Resistance 1 (R1) 21.56 21.53 21.35 21.48 22.09
Pivot Point 21.13 21.13 21.02 21.08 21.13
Support 1 (S1) 20.51 20.73 20.30 20.43 19.81
Support 2 (S2) 20.08 20.48 20.03 19.73
Support 3 (S3) 19.46 20.08 19.64
Support 4 (S4) 19.38